Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2006

View Archived Issues

MORAb-009 enters clinical development for mesothelin-expressing tumors

Fentanyl Taifun shows efficacy in breakthrough cancer pain

Disappointing phase IIb results for VLTS-934

New phase II study for Lymphoseek

CeNeS reports recent pipeline progress

MED-205 shows cholesterol-lowering activity in cholesterol animal model

BioInvent to focus on back-up compounds to BI-201 in HIV

New venture funding to support Elusys Therapeutics' HP Antibody pipeline

FDA lifts clinical hold on GENASIS trial

Predix receives milestone from Cystic Fibrosis Foundation Therapeutics

SIGA-246 for smallpox completes initial safety clinical trial

RAID Pilot Program supports development of EPI-A0001 for Friedreich's ataxia

Cardeva cleared to begin clinical trials in U.S.

Schering AG will not exercise option for EP-2104R

EuroPharma reports on preliminary clinical data for Vectomega

End-of-phase II meeting scheduled for Polynoma-1

Taiho licenses rights for Meiji Dairies' agent for cedar pollen allergy

Pycnogenol more effective than Daflon in reducing edema and walking pain

Neuroprotective action of minocycline associated to PARP-1 inhibition

Amgen's calcium-sensing receptor agonist AMG-641 beneficial in hyperparathyroidism secondary to CKD

Anti-PDGF-D monoclonal antibody may help delay mesangioproliferative nephritis progression

Oral Posiphen markedly attenuates Abeta-42 in vivo

Novel antibody-independent nasal vaccination for AD

CNI-1493 facilitates dramatic reductions in Abeta and microglial activity in AD

New agents for arthritis claimed in recent patent literature

Recent patents describe novel therapeutic agents for respiratory disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...